Axa
BIO icon

Axa’s Bio-Rad Laboratories Class A BIO Stock Holding History

Axa’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,200
Closed -$4.64M – 1233
2021
Q2 		$4.64M Buy
7,200
+6,500
+929% +$3.96M 0.01% 726
2021
Q1 		$400K Buy
+700
New +$415K ﹤0.01% 1101
2020
Q4 		– Sell
-1,000
Closed -$515K – 1265
2020
Q3 		$515K Sell
1,000
-400
-29% -$203K ﹤0.01% 1033
2020
Q2 		$632K Sell
1,400
-6,900
-83% -$3.04M ﹤0.01% 1026
2020
Q1 		$2.91M Buy
+8,300
New +$3.05M 0.01% 657
2015
Q2 		– Sell
-36,300
Closed -$4.91M – 1404
2015
Q1 		$4.91M Buy
36,300
+6,600
+22% +$818K 0.02% 608
2014
Q4 		$3.58M Buy
29,700
+25,100
+546% +$2.89M 0.01% 644
2014
Q3 		$521K Buy
+4,600
New +$545K ﹤0.01% 1055
2013
Q3 		– Sell
-2,100
Closed -$236K – 1283
2013
Q2 		$236K Buy
+2,100
New +$246K ﹤0.01% 1089

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return